284 related articles for article (PubMed ID: 25037313)
1. Prognosis by tumor location in adults with intracranial ependymomas.
Sayegh ET; Aranda D; Kim JM; Oh T; Parsa AT; Oh MC
J Clin Neurosci; 2014 Dec; 21(12):2096-101. PubMed ID: 25037313
[TBL] [Abstract][Full Text] [Related]
2. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
4. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
5. Survival After Resection of Newly-Diagnosed Intracranial Grade II Ependymomas: An Initial Multicenter Analysis and the Logistics of Intraoperative Magnetic Resonance Imaging.
Yahanda AT; Rich KM; Dacey RG; Zipfel GJ; Dunn GP; Dowling JL; Smyth MD; Leuthardt EC; Limbrick DD; Honeycutt J; Sutherland GR; Jensen RL; Evans J; Chicoine MR
World Neurosurg; 2022 Nov; 167():e757-e769. PubMed ID: 36028106
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in intracranial ependymomas in children.
Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic results of eight patients with intracranial ependymomas].
Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
[TBL] [Abstract][Full Text] [Related]
8. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
9. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
Aizer AA; Ancukiewicz M; Nguyen PL; Macdonald SM; Yock TI; Tarbell NJ; Shih HA; Loeffler JS; Oh KS
J Neurooncol; 2013 Dec; 115(3):411-9. PubMed ID: 24057324
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
[TBL] [Abstract][Full Text] [Related]
11. Prognosis by tumor location for pediatric spinal cord ependymomas.
Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
[TBL] [Abstract][Full Text] [Related]
12. Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.
Metellus P; Figarella-Branger D; Guyotat J; Barrie M; Giorgi R; Jouvet A; Chinot O;
Cancer; 2008 Jul; 113(1):175-85. PubMed ID: 18470910
[TBL] [Abstract][Full Text] [Related]
13. Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.
Metellus P; Guyotat J; Chinot O; Durand A; Barrie M; Giorgi R; Jouvet A; Figarella-Branger D
Neuro Oncol; 2010 Sep; 12(9):976-84. PubMed ID: 20484442
[TBL] [Abstract][Full Text] [Related]
14. Recursive partitioning analysis for disease progression in adult intracranial ependymoma patients.
Song SW; Dho YS; Kim JW; Kim YH; Paek SH; Kim DG; Jung HW; Park SH; Choi SH; Kim TM; Lee ST; Kim IH; Lee SH; Park CK
J Clin Neurosci; 2017 Dec; 46():72-78. PubMed ID: 28890044
[TBL] [Abstract][Full Text] [Related]
15. Supratentorial Extraventricular Ependymomas: Imaging Features and the Added Value of Apparent Diffusion Coefficient.
Wang X; Han F; Lv Y; Gao J; Du Z; Zhang J
J Comput Assist Tomogr; 2021 May-Jun 01; 45(3):463-471. PubMed ID: 34297516
[TBL] [Abstract][Full Text] [Related]
16. Supratentorial ependymomas in adult patients.
Schwartz TH; Kim S; Glick RS; Bagiella E; Balmaceda C; Fetell MR; Stein BM; Sisti MB; Bruce JN
Neurosurgery; 1999 Apr; 44(4):721-31. PubMed ID: 10201296
[TBL] [Abstract][Full Text] [Related]
17. The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study.
Wang L; Han S; Yan C; Yang Y; Li Z; Yang Z
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1259-1270. PubMed ID: 33387039
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in childhood intracranial ependymomas: the role of age and tumor location.
Sala F; Talacchi A; Mazza C; Prisco R; Ghimenton C; Bricolo A
Pediatr Neurosurg; 1998 Mar; 28(3):135-42. PubMed ID: 9705591
[TBL] [Abstract][Full Text] [Related]
19. Extraventricular site indicates higher grade but better prognosis in adult supratentorial ependymomas: a 14-year single-center retrospective cohort.
Chen S; Zuo M; Li T; Zhang S; Yang W; Chen N; Mao Q; Chen M; Liu Y
Neurosurg Rev; 2022 Dec; 45(6):3771-3778. PubMed ID: 36284077
[TBL] [Abstract][Full Text] [Related]
20. Both location and age predict survival in ependymoma: a SEER study.
McGuire CS; Sainani KL; Fisher PG
Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
